197A · TAUNS Laboratories, Inc. · Financials
Market Cap
56.61B JPY
Shares
106.81M
Volume · Nov 12
3.2M
Avg daily vol (3M)
260.96K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
14.37B
-22.9%
FY2026
Net Income
5.5B
-13%
FY2026
Gross Margin
61.39%
-7.2pp
FY2026
Operating Margin
29.23%
-15.1pp
FY2026
Operating Cash Flow
-2.83B
-141.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| JPY | 14.37B | 18.63B | 18.43B |
| JPY | 5.55B | 5.85B | 5.94B |
| JPY | 8.82B | 12.77B | 12.5B |
| JPY | 4.2B | 8.27B | 8.03B |
| JPY | 7.9B | 8.2B | 7.83B |
| JPY | 2.4B | 1.89B | 2.06B |
| JPY | 5.5B | 6.32B | 5.77B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 7.13B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.